NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

The MHRA performance summary indicated that they are not experiencing a backlog—this suggests the application has already been referred to the CHM, meaning the ball is no longer in their court. That makes it a safe and accurate statement for the MHRA to say they are not facing delays on their end.

Another BS claim. After the months-long patient site inspections, NWBO most probably faced a second RFI mid-March. The moment they sent NWBO a second RFI, the application was clocked off.